Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly L. Stark

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Disease|December 19, 2022
Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's diseaseRobert Brendza, Xiaoying Gao, Kimberly L Stark, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 26, 2020
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse ModelWilliam J Meilandt, Hai Ngu, Alvin Gogineni, et al.
Neuron|March 6, 2021
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathologySeung-Hye Lee, William J Meilandt, Luke Xie, et al.
Neuron|June 23, 2023
Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioidsLunbin Deng, Michelle Dourado, Rebecca M Reese, et al.
Journal of Neuroinflammation|September 30, 2025
Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brainsMonica Xiong, Lisa A Miosge, Carolina Correa-Ospina, et al.
Journal of Medicinal Chemistry|October 24, 2014
Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration modelsSnahel Patel, Frederick Cohen, Brian J Dean, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2024
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer's Disease and Multiple SclerosisAinhoa Etxeberria, Yun-An A Shen, Stephen Vito, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurobiology of Disease|December 19, 2022
Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's diseaseRobert Brendza, Xiaoying Gao, Kimberly L Stark, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 26, 2020
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse ModelWilliam J Meilandt, Hai Ngu, Alvin Gogineni, et al.
Neuron|March 6, 2021
Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathologySeung-Hye Lee, William J Meilandt, Luke Xie, et al.
Neuron|June 23, 2023
Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioidsLunbin Deng, Michelle Dourado, Rebecca M Reese, et al.
Journal of Neuroinflammation|September 30, 2025
Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brainsMonica Xiong, Lisa A Miosge, Carolina Correa-Ospina, et al.
Journal of Medicinal Chemistry|October 24, 2014
Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration modelsSnahel Patel, Frederick Cohen, Brian J Dean, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 3, 2024
Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer's Disease and Multiple SclerosisAinhoa Etxeberria, Yun-An A Shen, Stephen Vito, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 1, 2024
Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonismStephen P Schauer, Chang Hoon Cho, Gloriia Novikova, et al.
Pageof 2